| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Zhejiang CONBA Pharmaceutical Co.Ltd (SHG: 600572)
600572 Technical Analysis
5
| As on 9th Jun 2023 600572 STOCK Price closed @ 6.77 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.46 & Strong Buy for SHORT-TERM with Stoploss of 4.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
600572STOCK Price
| Open | 6.81 | Change | Price | % |
| High | 6.93 | 1 Day | -0.18 | -2.59 |
| Low | 6.68 | 1 Week | -0.18 | -2.59 |
| Close | 6.77 | 1 Month | 0.15 | 2.27 |
| Volume | 35685845 | 1 Year | 2.53 | 59.67 |
| 52 Week High 7.36 | 52 Week Low 3.85 | ||||
SHG China Most Active Stocks
| 600839 | 4.99 | 5.72% |
| 600050 | 5.31 | 2.51% |
| 601288 | 3.68 | -0.81% |
| 601988 | 4.13 | -0.48% |
| 601333 | 3.91 | -2.01% |
| 601360 | 14.30 | 1.13% |
| 601390 | 8.15 | 1.62% |
| 601818 | 3.29 | -0.60% |
| 601138 | 19.64 | 10.03% |
| 601398 | 5.07 | -0.39% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
| 600572 Daily Charts |
600572 Intraday Charts |
Whats New @ Bazaartrend |
600572 Free Analysis |
|
|
600572 Important Levels Intraday
| RESISTANCE | 7.25 |
| RESISTANCE | 7.10 |
| RESISTANCE | 7.00 |
| RESISTANCE | 6.91 |
| SUPPORT | 6.63 |
| SUPPORT | 6.54 |
| SUPPORT | 6.44 |
| SUPPORT | 6.29 |
600572 Forecast May 2024
| 4th UP Forecast | 8.58 |
| 3rd UP Forecast | 8 |
| 2nd UP Forecast | 7.64 |
| 1st UP Forecast | 7.28 |
| 1st DOWN Forecast | 6.26 |
| 2nd DOWN Forecast | 5.9 |
| 3rd DOWN Forecast | 5.54 |
| 4th DOWN Forecast | 4.96 |
600572 Weekly Forecast
| 4th UP Forecast | 7.00 |
| 3rd UP Forecast | 6.93 |
| 2nd UP Forecast | 6.88 |
| 1st UP Forecast | 6.84 |
| 1st DOWN Forecast | 6.70 |
| 2nd DOWN Forecast | 6.66 |
| 3rd DOWN Forecast | 6.61 |
| 4th DOWN Forecast | 6.54 |
600572 Forecast2024
| 4th UP Forecast | 13.73 |
| 3rd UP Forecast | 11.5 |
| 2nd UP Forecast | 10.12 |
| 1st UP Forecast | 8.74 |
| 1st DOWN Forecast | 4.8 |
| 2nd DOWN Forecast | 3.42 |
| 3rd DOWN Forecast | 2.04 |
| 4th DOWN Forecast | -0.19 |
Zhejiang CONBA Pharmaceutical Co.Ltd ( SHG China Symbol : 600572 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
600572 Business Profile
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of traditional Chinese medicines and botanical products in China. It offers chemical medicines, Chinese patent medicines, eye health products, nutritional supplements, health supplies, healthy daily necessities and food products, and other personal care products. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd. Address: No. 568, Binkang Road, Hangzhou, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service